Nomos launches remote treatment planning
A pioneer of intensity-modulated radiation therapy (IMRT), Nomos of Sewickley, PA, has launched a remote treatment planning service that promises to provide treatment facilities more rapid access to this type of radiation therapy. The product, Nomos Rx,
A pioneer of intensity-modulated radiation therapy (IMRT), Nomos of Sewickley, PA, has launched a remote treatment planning service that promises to provide treatment facilities more rapid access to this type of radiation therapy. The product, Nomos Rx, is aimed at treatment facilities that might not be able to implement a quality IMRT program due to the cost of resources and equipment required. IMRT allows the delivery of increased radiation doses to tumor while limiting the impact on surrounding healthy tissue.
Additionally, the privately held company has struck an agreement to partner with MCP International, a remarketer of radiation therapy equipment, to provide an IMRT package that includes a linear accelerator, multileaf collimator, CT scanner, and inverse treatment planning software. Nomos Peacock System will be coupled with MCP's refurbished digital linear accelerator and spiral CT scanning equipment to provide a turnkey integrated equipment package available for less than the cost of a new IMRT-capable linear accelerator.
FDA Grants Fast Track Designation to Emerging Agent for Brain PET Imaging
June 11th 2025Currently being evaluated in a phase 2b clinical trial, the 18F-RAD101 PET imaging agent garnered the FDA’s fast track designation for distinguishing between recurrent disease and treatment impact for brain metastases derived from solid tumors.
New PSMA PET Prep Product Now Available in the U.S.
June 11th 2025Offering an extended shelf life, the FDA-approved Gozellix, a preparation kit for gallium-68 (68Ga) gozetotide injection, is indicated for use in PSMA PET imaging of prostate cancer patients with suspected recurrence or metastasis.
